MedTrace Logo

Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer

NCT00210171 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2025-09-10

No results posted yet for this study

Summary

Feasibility of pragmatic concomitant chemo-radiotherapy association with 1 cycle of Induction chemotherapy, weekly chemo-radiotherapy, and consolidation chemotherapy.

Conditions

  • Carcinoma, Non-Small-Cell Lung

Interventions

PROCEDURE

Toxicity : Time to progression, 1 and 2 years survival

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Institut Bergonié

    lead OTHER

Principal Investigators

  • François CHOMY, MD · Institut Bergonié

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Primary Completion
2004-05-31
Completion
2004-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00210171 on ClinicalTrials.gov